| Tolvaptan in patients with autosomal dominant polycystic kidney disease. CFS Torres VE1, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ ... New England Journal of Medicine 25 (Dec 20;), 2407-18, 2012 | 1828* | 2012 |
| Tolvaptan in patients with autosomal dominant polycystic kidney disease. CFS Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ ... New England Journal of Medicine 367 (367(25)), 2407-18, 2012 | 1828 | 2012 |
| The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein CJ Ward, MC Hogan, S Rossetti, D Walker, T Sneddon, X Wang, V Kubly, ... Nature genetics 30 (3), 259-269, 2002 | 886 | 2002 |
| Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials MV Irazabal, LJ Rangel, EJ Bergstralh, SL Osborn, AJ Harmon, ... Journal of the American Society of Nephrology 26 (1), 160-172, 2015 | 708 | 2015 |
| Blood pressure in early autosomal dominant polycystic kidney disease RW Schrier, KZ Abebe, RD Perrone, VE Torres, WE Braun, TI Steinman, ... New England Journal of Medicine 371 (24), 2255-2266, 2014 | 556 | 2014 |
| Mutations in GANAB, encoding the glucosidase IIα subunit, cause autosomal-dominant polycystic kidney and liver disease B Porath, VG Gainullin, E Cornec-Le Gall, EK Dillinger, CM Heyer, ... The American Journal of Human Genetics 98 (6), 1193-1207, 2016 | 511* | 2016 |
| Response of Wegener's granulomatosis to anti‐CD20 chimeric monoclonal antibody therapy U Specks, FC Fervenza, TJ McDonald, MCE Hogan Arthritis & Rheumatism: Official Journal of the American College of …, 2001 | 424 | 2001 |
| Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease MC Hogan, TV Masyuk, LJ Page, VJ Kubly, EJ Bergstralh, X Li, B Kim, ... Journal of the American Society of Nephrology 21 (6), 1052-1061, 2010 | 411 | 2010 |
| Characterization of PKD protein-positive exosome-like vesicles MC Hogan, L Manganelli, JR Woollard, AI Masyuk, TV Masyuk, ... Journal of the American Society of Nephrology 20 (2), 278-288, 2009 | 373 | 2009 |
| Rituximab therapy in idiopathic membranous nephropathy: a 2-year study FC Fervenza, RS Abraham, SB Erickson, MV Irazabal, A Eirin, U Specks, ... Clinical journal of the American Society of Nephrology 5 (12), 2188-2198, 2010 | 356 | 2010 |
| Angiotensin blockade in late autosomal dominant polycystic kidney disease VE Torres, KZ Abebe, AB Chapman, RW Schrier, WE Braun, TI Steinman, ... New England Journal of Medicine 371 (24), 2267-2276, 2014 | 328 | 2014 |
| Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach CA Gadegbeku, DS Gipson, LB Holzman, AO Ojo, PXK Song, L Barisoni, ... Kidney international 83 (4), 749-756, 2013 | 325 | 2013 |
| Renal involvement in primary Sjögren's syndrome: a clinicopathologic study S Maripuri, JP Grande, TG Osborn, FC Fervenza, EL Matteson, ... Clinical Journal of the American Society of Nephrology 4 (9), 1423-1431, 2009 | 305 | 2009 |
| A randomized, controlled trial of rituximab in IgA nephropathy with proteinuria and renal dysfunction RA Lafayette, PA Canetta, BH Rovin, GB Appel, J Novak, KA Nath, S Sethi, ... Journal of the American Society of Nephrology 28 (4), 1306-1313, 2017 | 290 | 2017 |
| COVID-19 vaccination and glomerulonephritis N Klomjit, MP Alexander, FC Fervenza, Z Zoghby, A Garg, MC Hogan, ... Kidney international reports 6 (12), 2969-2978, 2021 | 203 | 2021 |
| The HALT polycystic kidney disease trials: design and implementation AB Chapman, VE Torres, RD Perrone, TI Steinman, KT Bae, JP Miller, ... Clinical Journal of the American Society of Nephrology 5 (1), 102-109, 2010 | 197 | 2010 |
| An eQTL landscape of kidney tissue in human nephrotic syndrome CE Gillies, R Putler, R Menon, E Otto, K Yasutake, V Nair, P Hoover, ... The American Journal of Human Genetics 103 (2), 232-244, 2018 | 183 | 2018 |
| Somatostatin analog therapy for severe polycystic liver disease: results after 2 years MC Hogan, TV Masyuk, L Page, DR Holmes III, X Li, EJ Bergstralh, ... Nephrology Dialysis Transplantation 27 (9), 3532-3539, 2012 | 179 | 2012 |
| DNAJB9 is a specific immunohistochemical marker for fibrillary glomerulonephritis SH Nasr, JA Vrana, S Dasari, F Bridoux, ME Fidler, S Kaaki, N Quellard, ... Kidney international reports 3 (1), 56-64, 2018 | 174 | 2018 |
| Extended follow-up of unruptured intracranial aneurysms detected by presymptomatic screening in patients with autosomal dominant polycystic kidney disease MV Irazabal, J Huston III, V Kubly, S Rossetti, JL Sundsbak, MC Hogan, ... Clinical Journal of the American Society of Nephrology 6 (6), 1274-1285, 2011 | 168 | 2011 |
Christopher WardKUMCZweryfikowany adres z kumc.edu
